The drug from hypertension nilvadipine reduces the risk of developing Alzheimer’s disease

Препарат от гипертонии нилвадипин снижает риск развития болезни Альцгеймера

To reduce the risk of developing Alzheimer’s disease, you can use some widespread drugs, scientists say. In particular, they point to nilvadipine.

According to the data obtained by researchers from the American heart Association, the drug – blocker calcium-channel nilvadipine (Nilvadipin) used for the treatment of hypertension and chronic occlusion of a major cerebral arteries, are capable of giving the effect to prevent the development of Alzheimer’s disease due to its ability to increase blood flow to the brain. About this time, according to Medicalxpress.

Recent studies have shown that in the early stages of Alzheimer’s disease blood flow to the brain ceases. In addition, the discovery was made that treatment of hypertension leads to a reduction in the risk of developing dementia. American researchers decided to find out whether intended for the therapy of hypertensive drug nilvadipine to help in the treatment of Alzheimer’s disease.

Scientists have analyzed the influence of drugs and placebo in people with Alzheimer’s disease of mild and moderate severity. They measured people blood flow to certain areas of the brain initially and then again after six months of taking the drug and placebo. The results showed that in the group of people taking nilvadipine compared to the placebo group 20% increase in blood flow in the hippocampus – the center of memory and learning. This stimulated a more active brain and stopped the formation of beta-amyloid plaques in the brain that are known to be harbingers of neural degeneration leading to dementia and its variations.

Share